ALEXANDER WATSON: Open Payments
NPI 1710576442 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 109 payments from 19 companies in 2025. Trend: 2023 $1,416 · 2024 $2,265 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $452 |
| Novo Nordisk Inc | 12 | $200 |
| PFIZER INC. | 17 | $160 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Amgen Inc. | 5 | $105 |
| Lilly USA, LLC | 5 | $104 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
Products named: VRAYLAR, UBRELVY, NURTEC ODT, REXULTI, Wegovy, FARXIGA, MOUNJARO, Kerendia.
Industry payments across NC — which companies pay providers there.
